SCHEMBL4725091

SCHEMBL4725091

O=C1NCCCN1.O=C1NCCCN1

nearest known ligand 0.47

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
OR51E2 Q9H255 1/20 0.47
CRBN Q96SW2 4/20 0.45
FKBP5 Q13451 1/20 0.45
KMT2A Q03164 1/20 0.31
KDM4E B2RXH2 2/20 0.30
GAA P10253 1/20 0.30
POLB P06746 1/20 0.30
ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL88886 1.00
SCHEMBL30957985 0.96
Hydrochloric Acid SCHEMBL29778326 0.96 OR51E2 (0.45) OR51E2CRBNFKBP5
SCHEMBL279773 0.92
SCHEMBL540697 0.89
SCHEMBL821040 0.89 CRBN (0.50) OR51E2CRBNFKBP5KDM4EGAA
SCHEMBL820531 0.89 CRBN (0.50) OR51E2CRBNFKBP5KDM4EGAA
SCHEMBL21423158 0.89 CRBN (0.50) OR51E2CRBNFKBP5KDM4EGAA
SCHEMBL8089176 0.89 CRBN (0.50) OR51E2CRBNFKBP5KDM4EGAA
SCHEMBL820411 0.89 CRBN (0.50) OR51E2CRBNFKBP5KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008027075-A2 SULFHYDRYL-REACTIVE, WATER SOLUBLE DYES THE SCRIPPS RESEARCH INSTITUTE (US) 2008-03-06 WO disclosed
EP-0962457-B1 Piperidones as tachykinin antagonists PFIZER LTD (GB) 2003-08-06 EP disclosed
EP-0790248-B1 3-Aza-piperidone- (tetrahydropyrimidin-2-one) and 3-oxa-piperidone (1,3 oxazin-2-one) derivatives, their preparation and their use as tachykinin/neurokinin antagonists PFIZER LTD (GB) 2003-05-28 EP disclosed
EP-0790248-A1 3-Aza-piperidone- (tetrahydropyrimidin-2-one) and 3-oxa-piperidone (1,3 oxazin-2-one) derivatives, their preparation and their use as tachykinin/neurokinin antagonists Pfizer Limited (GB) 1997-08-20 EP disclosed